Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid Tumors

Clinical trial NCT04764084 · UNKNOWN

Trial details

NCT number: NCT04764084
Sponsor: Peking University Cancer Hospital & Institute
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

HER2-negative Breast Cancer Gastric Adenocarcinoma Cholangiocarcinoma Pancreatic Cancer

Start date: 2021-04-01
Primary completion: 2021-11-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.